Latest updates for Nejm
Fresh curated links around nejm are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- The epicenter of a crisis in modern medical care
- Johnson & Johnson presents new data further reinforcing the role of nipocalimab in lowering the autoantibodies drivi
- Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) di
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
qchron.com
/1 month ago
Johnson & Johnson presents new data further reinforcing the role of nipocalimab in lowering the autoantibodies drivi...
Nipocalimab, an immunoselective neonatal Fc receptor (FcRn) blocker, is designed to target and reduce pathogenic immunoglobulin G (IgG) autoantibodies associated with Sjögren's dis...
qchron.com
/1 month ago
Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) di...
Nipocalimab – the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and reduce pathogenic immunoglobulin G (I...
greatergood.berkeley.edu
/1 month ago
Introducing - Intention to Treat: Money and Misdiagnosis
Intention to Treat: The Race Equation is a new series from the New England Journal of Medicine, investigates how race-specific diagnostic tools harm Black patients and contribute t...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Nejm
drsvenkatesan.com
Recent coverage from public sources
Public source
greatergood.berkeley.edu
Recent coverage from public sources
Public source
qchron.com
Recent coverage from public sources
Public source